Minireview: update on incretin biology: focus on glucagon-like peptide-1.
Brubaker
Patricia L
PL
Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada. p.brubaker@utoronto.ca
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism*; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism / Q000494:pharmacology; D054795:Incretins / Q000378:metabolism* / Q000494:pharmacology; D050417:Insulin-Secreting Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D018027:Receptors, Glucagon / Q000819:agonists / Q000378:metabolism
D007004:Hypoglycemic Agents; D054795:Incretins; D018027:Receptors, Glucagon; D052216:Glucagon-Like Peptide 1